title: Endophthalmitis following open-globe injuries.
abstract: The incidence of traumatic endophthalmitis may be decreasing due to earlier wound closure and prompt initiation of antibiotics. Risk factors for endophthalmitis include retained intraocular foreign body, rural setting of injury, disruption of the crystalline lens, and a delay in primary wound closure. The microbiology in the post-traumatic setting includes a higher frequency of virulent organisms such as Bacillus species. Recognizing early clinical signs of endophthalmitis, including pain, hypopyon, vitritis, or retinal periphlebitis may prompt early treatment with intravitreal antibiotics. Prophylaxis of endophthalmitis in high-risk open-globe injuries may include systemic broad-spectrum antibiotics, topical antibiotics, and intravitreal antibiotics to cover both Gram-positive and Gram-negative bacteria. For clinically diagnosed post-traumatic endophthalmitis, intravitreal vancomycin, and ceftazidime are routinely used. Concurrent retinal detachment with endophthalmitis can be successfully managed with vitrectomy and use of intravitreal antibiotics along with a long acting gas or silicone oil tamponade. Endophthalmitis is a visually significant complication of open-globe injuries but early wound closure as well as comprehensive prophylactic antibiotic treatment at the time of injury repair may improve visual acuity outcomes.
authors: Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami, Miller School of Medicine, Miami, FL 33136, USA.
authors: Y
authors: Y
authors: Ahmed
authors: A M
authors: AM
authors: Schimel
authors: A
authors: A
authors: Pathengay
authors: M H
authors: MH
authors: Colyer
authors: H W
authors: HW
authors: Flynn
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D009877:Endophthalmitis / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control; D005129:Eye Foreign Bodies / Q000150:complications / Q000601:surgery; D015807:Eye Injuries, Penetrating / Q000150:complications* / Q000628:therapy; D006801:Humans; D015994:Incidence; D012163:Retinal Detachment / Q000150:complications*; D012307:Risk Factors; D014792:Visual Acuity
chemical_list: D000900:Anti-Bacterial Agents